Zurich Cantonal Bank’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-14,660
| Closed | -$31.1K | – | 2754 |
|
2023
Q3 | $31.1K | Hold |
14,660
| – | – | ﹤0.01% | 2675 |
|
2023
Q2 | $69.8K | Hold |
14,660
| – | – | ﹤0.01% | 2504 |
|
2023
Q1 | $83.6K | Hold |
14,660
| – | – | ﹤0.01% | 2384 |
|
2022
Q4 | $148K | Buy |
14,660
+4,685
| +47% | +$47.3K | ﹤0.01% | 2014 |
|
2022
Q3 | $224K | Hold |
9,975
| – | – | ﹤0.01% | 1682 |
|
2022
Q2 | $247K | Hold |
9,975
| – | – | ﹤0.01% | 1674 |
|
2022
Q1 | $387K | Sell |
9,975
-3,385
| -25% | -$131K | ﹤0.01% | 1487 |
|
2021
Q4 | $782K | Buy |
13,360
+5,135
| +62% | +$301K | ﹤0.01% | 1144 |
|
2021
Q3 | $487K | Sell |
8,225
-13
| -0.2% | -$770 | ﹤0.01% | 1317 |
|
2021
Q2 | $715K | Buy |
8,238
+32
| +0.4% | +$2.78K | ﹤0.01% | 1023 |
|
2021
Q1 | $677K | Sell |
8,206
-1,291
| -14% | -$107K | ﹤0.01% | 1039 |
|
2020
Q4 | $864K | Buy |
9,497
+2,573
| +37% | +$234K | 0.01% | 1008 |
|
2020
Q3 | $277K | Hold |
6,924
| – | – | ﹤0.01% | 1381 |
|
2020
Q2 | $238K | Buy |
6,924
+1,745
| +34% | +$60K | ﹤0.01% | 1414 |
|
2020
Q1 | $115K | Buy |
5,179
+2,245
| +77% | +$49.9K | ﹤0.01% | 1528 |
|
2019
Q4 | $57K | Hold |
2,934
| – | – | ﹤0.01% | 2071 |
|
2019
Q3 | $46K | Hold |
2,934
| – | – | ﹤0.01% | 2095 |
|
2019
Q2 | $60K | Hold |
2,934
| – | – | ﹤0.01% | 1942 |
|
2019
Q1 | $52K | Sell |
2,934
-931
| -24% | -$16.5K | ﹤0.01% | 1976 |
|
2018
Q4 | $50K | Buy |
3,865
+1,464
| +61% | +$18.9K | ﹤0.01% | 2027 |
|
2018
Q3 | $39K | Buy |
+2,401
| New | +$39K | ﹤0.01% | 2278 |
|